Rituximab Monotherapy for Primary Cutaneous Follicle Center Lymphoma
Journal Title: Journal of Advances in Internal Medicine - Year 2012, Vol 1, Issue 1
Abstract
Primary cutaneous follicle center lymphoma is a rare disorder. Although there are several treatment options, large clinical trials on the treatment of primary cutaneous follicle center lymphoma are lacking. Optimal treatment of this disease is unclear. We describe a case of primary cutaneous follicle center lymphoma treated with systemic rituximab, and review the literature.
Authors and Affiliations
Ajay Dhakal| Clinical Observer,St. Joseph Regional Medical Center, Lewiston ID, USA, David M Tretheway| Pathologist,St. Joseph Regional Medical Center, Lewiston ID, USA, Rebecca Fulton| Pathologist,St. Joseph Regional Medical Center, Lewiston ID, USA, Binay Kumar Shah*| Hematologist and Medical Oncologist,St. Joseph Regional Medical Center, Lewiston ID, USA
Concurrent multiple intracranial and intramedullary tuberculoma: a rare form of neurotuberculosis
Central nervous system tuberculosis is a serious form of tuberculosis. Tuberculous CNS involvement can occur in the form of TB meningitis, tuberculous Vasculitis, tuberculoma and rarely brain abscess. Tubercular granulom...
-119C/G in MYG1 Gene and 49A/G in CTLA4 Gene Polymorphisms in Turkish Patients with Vitiligo
Vitiligo is a disease characterized by sharply limited white macular depigmentation as a result of melanocyte loss. Disease is divided into three types according to prevalence and localization as localized, general and u...
Immunology of the gut and oral tolerance
The pathogens and harmless antigens from the bacterial flora and food constantly expose the mucosal surface of the gastrointestinal tract. The mucosal epithelial cells act not only as a physical barrier, but also as a lo...
RESPONSE OF CANOLA (BRASSICA NAPUS L.) CULTIVARS TO SOWING DATE AND ROW SPACING
The effect of sowing date (SD) and row spacing (RS) on canola (Brassica napus L.) cultivars was studied in a field experiment conducted for two years (2000-2002). The experiment was a randomized complete block design arr...
Role of Peroxisome Proliferator Activated Receptor-gamma and its Ligands in Inflammatory Bowel Disease
Peroxisome proliferator-activated receptor-gamma (PPAR-γ), a nuclear receptor, is highly expressed in the colonic epithelium in contrast to its impaired expression in the patients with ulcerative colitis (UC). Several na...